biOasis Technologies Inc.

(BTI:CX2)

By |

Profile

Bioasis Technologies Inc is a biopharmaceutical company developing xB3, a proprietary technology for the delivery of therapeutics across the blood-brain barrier and the treatment of CNS disorders, including brain cancers and neurodegenerative diseases.

Contact Information

Website: www.bioasis.us
Email: info@bioasis.us
Main Phone: +1 917 763-2709
Address: 14 Water Street
Address 2: Suite 130
State: CT
City / Town: Guilford
Country: USA
Postal Code: 06437

Issuer Information

Exchange: CDX
CEO: Mark Day
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 0.46 $ -0.01 (-2.13%)
Last Price 0.46 Change $ -0.01 Change % -2.13 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.46 High 0.46 Low 0.46 Prev Close 0.47
Last Trade Volume 2,200 52 Wk Hi 1.07 52 Wk Low 0.44
Market Cap 26.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 56,825,250.00 EPS (TTM) -0.09 PE Ratio N/A Exchange TSXV
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2 2 2 2
Low Target Price Estimate 2 2 2 2
Mean Target Price Estimate 2 2 2 2
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 04/17/14 04/17/14 04/17/14 04/17/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1